A share price of Labcorp Holdings Inc. [LH] is currently trading at $213.06, up 1.10%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LH shares have gain 2.88% over the last week, with a monthly amount glided 4.69%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Labcorp Holdings Inc. [NYSE: LH] stock has seen the most recent analyst activity on March 25, 2024, when Argus upgraded its rating to a Buy but kept the price target unchanged to $250 for it. Previously, Leerink Partners started tracking the stock with Outperform rating on February 26, 2024, and set its price target to $260. On February 09, 2024, Evercore ISI initiated with a In-line rating and assigned a price target of $240 on the stock. Barclays started tracking the stock assigning a Equal Weight rating and suggested a price target of $222 on January 03, 2024. HSBC Securities initiated its recommendation with a Hold and recommended $210 as its price target on September 06, 2023. Citigroup downgraded its rating to Neutral for this stock on December 12, 2022, and downed its price target to $250. In a note dated September 19, 2022, Argus downgraded an Hold rating on this stock.
Labcorp Holdings Inc. experienced fluctuations in its stock price throughout the past year between $191.97 and $234.09. Currently, Wall Street analysts expect the stock to reach $306.75 within the next 12 months. Labcorp Holdings Inc. [NYSE: LH] shares were valued at $213.06 at the most recent close of the market. An investor can expect a potential return of 43.97% based on the average LH price forecast.
Analyzing the LH fundamentals
Trailing Twelve Months sales for Labcorp Holdings Inc. [NYSE:LH] were 12.30B which represents -15.92% decline. Gross Profit Margin for this corporation currently stands at 0.27% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.04%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.05 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.66.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 210.53 points at the first support level, and at 208.01 for the second support level. However, for the 1st resistance point, the stock is sitting at 215.16, and for the 2nd resistance point, it is at 217.27.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Labcorp Holdings Inc. [NYSE:LH] is 0.88. Also, the Quick Ratio is 0.76, while the Cash Ratio stands at 0.03. Considering the valuation of this stock, the price to sales ratio is 1.46, the price to book ratio is 2.26 and price to earnings (TTM) ratio is 43.02.
Transactions by insiders
Recent insider trading involved van der Vaart Sandra D, EVP, Chief Legal Officer, that happened on May 14 ’24 when 2000.0 shares were sold. Director, ANDERSON KERRII B completed a deal on May 02 ’24 to sell 250.0 shares. Meanwhile, Director ANDERSON KERRII B sold 250.0 shares on Apr 30 ’24.
